<div>1. Royal College of Physicians, Why Asthma Still Kills: the National
Review of Asthma Deaths (NRAD) Confidential Enquiry Report. London, RCP,
2014. .
www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf.</div><div>2. Collaborators GBDCRD. Prevalence and attributable health burden of
chronic respiratory diseases, 1990-2017: a systematic analysis for the
Global Burden of Disease Study 2017. The Lancet Respiratory medicine.
2020;8(6):585-96.</div><div>3. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled
corticosteroids and the prevention of death from asthma. N Engl J Med.
2000;343(5):332-6.</div><div>4. Dhruve H, d’Ancona G, Holmes S, Dhariwal J, Nanzer AM, Jackson DJ.
Prescribing Patterns and Treatment Adherence in Patients with Asthma
During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2021.</div><div>5. Horne R. Compliance, adherence, and concordance: implications for
asthma treatment. Chest. 2006;130(1 Suppl):65s-72s.</div><div>6. Jansen EM, van de Hei SJ, Dierick BJH, Kerstjens HAM, Kocks JWH, van
Boven JFM. Global burden of medication non-adherence in chronic
obstructive pulmonary disease (COPD) and asthma: a narrative review of
the clinical and economic case for smart inhalers. J Thorac Dis.
2021;13(6):3846-64.</div><div>7. Vähätalo I, Ilmarinen P, Tuomisto LE, Tommola M, Niemelä O, Lehtimäki
L, et al. 12-year adherence to inhaled corticosteroids in adult-onset
asthma. ERJ Open Res. 2020;6(1).</div><div>8. Holmes J, Heaney LG. Measuring adherence to therapy in airways
disease. Breathe (Sheff). 2021;17(2):210037.</div><div>9. Chan AHY, Harrison J, Black PN, Mitchell EA, Foster JM. Using
Electronic Monitoring Devices to Measure Inhaler Adherence: A Practical
Guide for Clinicians. The Journal of Allergy and Clinical Immunology: In
Practice. 2015;3(3):335-49.e5.</div><div>10. Horne R, Weinman J. Self-regulation and Self-management in Asthma:
Exploring The Role of Illness Perceptions and Treatment Beliefs in
Explaining Non-adherence to Preventer Medication. Psychology &amp; Health.
2002;17(1):17-32.</div><div>11. Janežič A, Locatelli I, Kos M. Criterion validity of 8-item Morisky
Medication Adherence Scale in patients with asthma. PLoS One.
2017;12(11):e0187835.</div><div>12. Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de
Llano LP, et al. Validation of the ’Test of the Adherence to Inhalers’
(TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv.
2016;29(2):142-52.</div><div>13. Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall
M, et al. Accuracy of patient self-report as a measure of inhaled asthma
medication use. Respirology. 2013;18(3):546-52.</div><div>14. Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM.
Medication adherence and the risk of severe asthma exacerbations: a
systematic review. Eur Respir J. 2015;45(2):396-407.</div><div>15. Tibble H, Lay-Flurrie J, Sheikh A, Horne R, Mizani MA, Tsanas A, et
al. Linkage of primary care prescribing records and pharmacy dispensing
Records in the Salford Lung Study: application in asthma. BMC Medical
Research Methodology. 2020;20(1):303.</div><div>16. George KE, Ryan DM, Keevil B, Niven R, Fowler SJ. A pilot study to
investigate the use of serum inhaled corticosteroid concentration as a
potential marker of treatment adherence in severe asthma. J Allergy Clin
Immunol. 2017;139(3):1037-9.e1.</div><div>17. Alahmadi FH, Keevil B, Elsey L, George K, Niven R, Fowler SJ. Serum
Inhaled Corticosteroid Detection for Monitoring Adherence in Severe
Asthma. The Journal of Allergy and Clinical Immunology: In Practice.
2021.</div><div>18. Heaney LG, Busby J, Bradding P, Chaudhuri R, Mansur AH, Niven R, et
al. Remotely Monitored Therapy and Nitric Oxide Suppression Identifies
Nonadherence in Severe Asthma. Am J Respir Crit Care Med.
2019;199(4):454-64.</div><div>19. Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP,
Heaney LG, et al. FeNO Non-Suppression Identifies
Corticosteroid-Resistant Type-2 Signaling in Severe Asthma. Am J Respir
Crit Care Med. 2021.</div><div>20. D’Arcy S, MacHale E, Seheult J, Holmes MS, Hughes C, Sulaiman I, et
al. A method to assess adherence in inhaler use through analysis of
acoustic recordings of inhaler events. PLoS One. 2014;9(6):e98701.</div><div>21. Seheult JN, O’Connell P, Tee KC, Bholah T, Al Bannai H, Sulaiman I,
et al. The acoustic features of inhalation can be used to quantify
aerosol delivery from a Diskus™ dry powder inhaler. Pharm Res.
2014;31(10):2735-47.</div><div>22. Sulaiman I, Greene G, MacHale E, Seheult J, Mokoka M, D’Arcy S, et
al. A randomised clinical trial of feedback on inhaler adherence and
technique in patients with severe uncontrolled asthma. European
Respiratory Journal. 2018;51(1):1701126.</div><div>23. Sulaiman I, Seheult J, MacHale E, Boland F, O’Dwyer SM, Rapcan V, et
al. A Method to Calculate Adherence to Inhaled Therapy that Reflects the
Changes in Clinical Features of Asthma. Ann Am Thorac Soc.
2016;13(11):1894-903.</div><div>24. Sulaiman I, Seheult J, MacHale E, D’Arcy S, Boland F, McCrory K, et
al. Irregular and Ineffective: A Quantitative Observational Study of the
Time and Technique of Inhaler Use. The Journal of Allergy and Clinical
Immunology: In Practice. 2016;4(5):900-9.e2.</div><div>25. Taylor TE, Zigel Y, Egan C, Hughes F, Costello RW, Reilly RB.
Objective Assessment of Patient Inhaler User Technique Using an
Audio-Based Classification Approach. Sci Rep. 2018;8(1):2164.</div><div>26. Boddy CE, Naveed S, Craner M, Murphy AC, Siddiqui S, Bradding P.
Clinical Outcomes in People with Difficult-to-Control Asthma Using
Electronic Monitoring to Support Medication Adherence. J Allergy Clin
Immunol Pract. 2021;9(4):1529-38.e2.</div><div>27. Greene G, Costello RW, Cushen B, Sulaiman I, Mac Hale E, Conroy RM,
et al. A novel statistical method for assessing effective adherence to
medication and calculating optimal drug dosages. PLoS One.
2018;13(4):e0195663.</div><div>28. INCA http://www.incadevice.com [Accessed 26/10/21]</div><div>29. Propeller Health https://propellerhealth.com [Accessed
26/10/21]</div><div>30. Merchant RK, Inamdar R, Quade RC. Effectiveness of Population Health
Management Using the Propeller Health Asthma Platform: A Randomized
Clinical Trial. J Allergy Clin Immunol Pract. 2016;4(3):455-63.</div><div>31. Barrett MA, Humblet O, Marcus JE, Henderson K, Smith T, Eid N, et
al. Effect of a mobile health, sensor-driven asthma management platform
on asthma control. Ann Allergy Asthma Immunol. 2017;119(5):415-21.e1.</div><div>32. Williams AM, Phaneuf DJ, Barrett MA, Su JG. Short-term impact of
PM(2.5) on contemporaneous asthma medication use: Behavior and the value
of pollution reductions. Proc Natl Acad Sci U S A. 2019;116(12):5246-53.</div><div>33. Merchant R, Szefler SJ, Bender BG, Tuffli M, Barrett MA, Gondalia R,
et al. Impact of a digital health intervention on asthma resource
utilization. World Allergy Organ J. 2018;11(1):28.</div><div>34. De Keyser HEH, Kaye L, Anderson WC, Gondalia R, Theye B, Szefler SJ,
et al. Electronic medication monitors help determine adherence subgroups
in asthma. Respir Med. 2020;164:105914.</div><div>35. Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA.
Changes in medication adherence among patients with asthma and COPD
during the COVID-19 pandemic. J Allergy Clin Immunol Pract.
2020;8(7):2384-5.</div><div>36. Mosnaim GS, Stempel DA, Gonzalez C, Adams B, BenIsrael-Olive N,
Gondalia R, et al. The Impact of Patient Self-Monitoring Via Electronic
Medication Monitor and Mobile App Plus Remote Clinician Feedback on
Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial. J
Allergy Clin Immunol Pract. 2021;9(4):1586-94.</div><div>37. Hailie https://www.hailie.com/ [Accessed 26/10/21]</div><div>38. Makhecha S, Chan A, Pearce C, Jamalzadeh A, Fleming L. Novel
electronic adherence monitoring devices in children with asthma: a
mixed-methods study. BMJ Open Respir Res. 2020;7(1).</div><div>39. Foster JM, Usherwood T, Smith L, Sawyer SM, Xuan W, Rand CS, et al.
Inhaler reminders improve adherence with controller treatment in primary
care patients with asthma. Journal of Allergy and Clinical Immunology.
2014;134(6):1260-8.e3.</div><div>40. Morton RW, Elphick HE, Rigby AS, Daw WJ, King DA, Smith LJ, et al.
STAAR: a randomised controlled trial of electronic adherence monitoring
with reminder alarms and feedback to improve clinical outcomes for
children with asthma. Thorax. 2017;72(4):347-54.</div><div>41. Pilcher J, Shirtcliffe P, Patel M, McKinstry S, Cripps T, Weatherall
M, et al. Three-month validation of a turbuhaler electronic monitoring
device: implications for asthma clinical trial use. BMJ Open Respiratory
Research. 2015;2(1):e000097.</div><div>42. O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C,
et al. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
N Engl J Med. 2018;378(20):1865-76.</div><div>43. Turboplus http://turbuplusinfo.co.uk [Accessed 26/10/21]</div><div>44. Kuipers E, Poot CC, Wensing M, Chavannes NH, de Smet PA, Teichert M.
Self-Management Maintenance Inhalation Therapy With eHealth (SELFIE):
Observational Study on the Use of an Electronic Monitoring Device in
Respiratory Patient Care and Research. J Med Internet Res.
2019;21(5):e13551.</div><div>45. CapMedic https://capmedicinhaler.com [Accessed 26/10/21]</div><div>46. Biswas R, Patel G, Mohsin A, Hanania N, Sabharwal A. Measuring
Competence in Metered Dose Inhaler Use Using Capmedic Electronic Inhaler
Monitoring Tool. CHEST. 2016;150(4):14A.</div><div>47. Landon C, Biswas R, Wicklund H, Wallace K, Thompson A. Utilizing
Capmedic Electronic Device to Measure and Improve Inhaler Technique in
Clinic. C32 FACTORS IN ADHERENCE AND CONTROL OF ASTHMA. p. A4786-A.</div><div>48. Braido F, Paa F, Ponti L, Canonica G. A new tool for inhalers’ use
and adherence monitoring: the Amiko® validation trial. Int J Eng Res
Sci. 2016;2(10):159-66.</div><div>49. Respiro Amiko https://www.amiko.io [Accessed 26/10/21]</div><div>50. HeroTracker https://coherohealth.com [Accessed 26/10/21]</div><div>51. Digihaler https://www.digihalerhcp.com/ [Accessed
26/10/21]</div><div>52. Granovsky L, Li T, Reich M, Cohen S, Hadar Y, Pleasants R, et al. A
Predictive Model for Clinical Asthma Exacerbations Using Albuterol eMDPI
(ProAir Digihaler): A 12-Week, Open-Label Study. A31 ASTHMA: CLINICAL
STUDIES I. p. A7307-A.</div>